Evidence map›Paper›PMID 40385447›Full record

ArticlemedRxiv : the preprint server for health sciences2025

Predicting Bacterial Vaginosis Development using Artificial Neural Networks.

Jacob H Elnaggar, John W Lammons, Caleb M Ardizzone, Kristal J Aaron, Clayton Jacobs, Keonte J Graves, Sheridan D George, Meng Luo, Ashutosh Tamhane, Paweł Łaniewski and 5 more

Abstract readPreprint
In one paragraph

Article in medRxiv : the preprint server for health sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

15 authors.

Jacob H ElnaggarDepartment of Microbiology, Immunology, and Parasitology, Louisiana State University Health Sciences Center; New Orleans, Louisiana, USA.
John W LammonsDepartment of Microbiology, Immunology, and Parasitology, Louisiana State University Health Sciences Center; New Orleans, Louisiana, USA.
Caleb M ArdizzoneDepartment of Microbiology, Immunology, and Parasitology, Louisiana State University Health Sciences Center; New Orleans, Louisiana, USA.
Kristal J AaronDivision of Infectious Diseases, Department of Medicine, University of Alabama at Birmingham; Birmingham, Alabama, USA.
Clayton JacobsDepartment of Microbiology, Immunology, and Parasitology, Louisiana State University Health Sciences Center; New Orleans, Louisiana, USA.
Keonte J GravesDivision of Infectious Diseases, Department of Medicine, University of Alabama at Birmingham; Birmingham, Alabama, USA.ORCID 0000-0002-8646-3801
Sheridan D GeorgeDivision of Infectious Diseases, Department of Medicine, University of Alabama at Birmingham; Birmingham, Alabama, USA.
Meng LuoDepartment of Microbiology, Immunology, and Parasitology, Louisiana State University Health Sciences Center; New Orleans, Louisiana, USA.
Ashutosh TamhaneDivision of Nephrology, Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA.
Paweł ŁaniewskiDepartment of Basic Medical Sciences, College of Medicine-Phoenix, University of Arizona, Phoenix, Arizona, USA.ORCID 0000-0002-5190-2173
Alison J QuayleDepartment of Microbiology, Immunology, and Parasitology, Louisiana State University Health Sciences Center; New Orleans, Louisiana, USA.
Melissa M Herbst-KralovetzDepartment of Basic Medical Sciences, College of Medicine-Phoenix, University of Arizona, Phoenix, Arizona, USA.ORCID 0000-0002-8540-5917
Nuno CercaCentre of Biological Engineering, Laboratory of Research in Biofilms Rosário Oliveira, Minho University, Braga, Portugal.ORCID 0000-0003-3365-3537
Christina A MuznyDivision of Infectious Diseases, Department of Medicine, University of Alabama at Birmingham; Birmingham, Alabama, USA.ORCID 0000-0002-4005-3858
Christopher M TaylorDepartment of Microbiology, Immunology, and Parasitology, Louisiana State University Health Sciences Center; New Orleans, Louisiana, USA.

Funding

National Dissemination of I-Corps@NCATS: Accelerating Translation through CommercializationUL1TR003096 · NCATS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI GUTIERREZ, ORLANDO M, KIMBERLY, ROBERT P. · 2019 to 2023
$43.6M
Uranium as an Environmental Risk Factor for Cancer Among the NavajoU54CA143924 · NCI · UNIVERSITY OF ARIZONA · PI Melissa Marie Herbst-Kralovetz, JUANITA L. MERCHANT · 2009 to 2026
$26.7M
Microbial Interactions between Gardnerella, Prevotella, and Atopobium Prior to Incident Bacterial VaginosisR01AI146065 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI MUZNY, CHRISTINA A · 2020 to 2024
$3.2M
Consequences of vaginal microbiota on IFNγ-mediated clearance of Chlamydia trachomatisR01AI118860 · NIAID · LSU HEALTH SCIENCES CENTER · PI AIYAR, ASHOK A, QUAYLE, ALISON J. · 2017 to 2020
$2.4M
NCATS NIH HHS UL1 TR003096NCI NIH HHS U54 CA143924NIAID NIH HHS R01 AI118860NIAID NIH HHS R01 AI146065
6 · The paper itself

Abstract

Bacterial vaginosis (BV) is a dysbiosis of the vaginal microbiome, characterized by the depletion of protective

Indexed as

Artificial Neural NetworkBacterial VaginosisEarly-DetectionVaginal Microbiome

Identifiers

PMID40385447
PMCPMC12083586

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.